HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susan M Pullen Selected Research

Radiotherapy

7/2007Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susan M Pullen Research Topics

Disease

5Hypoxia (Hypoxemia)
01/2015 - 06/2007
5Neoplasms (Cancer)
11/2014 - 03/2002
1Hepatocellular Carcinoma (Hepatoma)
01/2015
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
03/2014

Drug/Important Bio-Agent (IBA)

5ProdrugsIBA
11/2014 - 03/2002
4PR-104IBA
01/2015 - 07/2007
4DNA (Deoxyribonucleic Acid)IBA
01/2015 - 07/2007
3PR-104AIBA
03/2014 - 07/2007
2Hydroxylamine (Hydroxylamine Hydrochloride)IBA
01/2015 - 07/2007
2Cytotoxins (Cytolysins)IBA
11/2014 - 06/2007
2tretazicarIBA
06/2004 - 03/2002
1Sorafenib (BAY 43-9006)FDA Link
01/2015
1AminesIBA
01/2015
1Aldo-Keto ReductasesIBA
01/2015
1Oxidoreductases (Dehydrogenase)IBA
01/2015
1NitrogenIBA
11/2014
1Cisplatin (Platino)FDA LinkGeneric
11/2014
1Messenger RNA (mRNA)IBA
03/2014
1SN 34037IBA
03/2014
1Biomarkers (Surrogate Marker)IBA
05/2009
1Docetaxel (Taxotere)FDA Link
07/2007
1Tirapazamine (SR 4233)IBA
07/2007
1GemcitabineFDA Link
07/2007
1nitromide (Unistat)IBA
07/2007
1Mechlorethamine (Nitrogen Mustard)FDA Link
07/2007
1SolutionsIBA
06/2007
1Oxygen (Dioxygen)IBA
06/2007
1NADPH-Ferrihemoprotein Reductase (Cytochrome P450 Reductase)IBA
06/2007
1EnzymesIBA
03/2002

Therapy/Procedure

1Drug Therapy (Chemotherapy)
07/2007
1Aftercare (After-Treatment)
07/2007
1Radiotherapy
07/2007
1Therapeutics
03/2002